中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)32575.3721875.6710832.2583551.0074612.79
营业收入(万元)32575.3721875.6710832.2583551.0074612.79
营业总成本(万元)34630.3722834.9211160.4751716.2336644.78
营业成本(万元)24207.7716505.147998.6635195.2522573.69
净利润(万元)-265.38-177.93206.8424094.6431319.08
归属于母公司的净利润(万元)-265.38-177.93206.8424307.2731319.08
营业利润(万元)-714.88-114.87247.6932168.3938189.61
利润总额(万元)-1089.72-133.33245.2231653.3437961.51
少数股东损益(万元)----------
基本每股收益(元)-0.02(元)-0.01(元)0.02(元)1.93(元)2.49(元)
稀释每股收益(元)-0.02(元)-0.01(元)0.02(元)1.93(元)2.49(元)
非经常性损益(万元)768.82618.77------
扣除非经常性损益后净利润(万元)-1034.19-796.70-64.1423197.0230427.81
总资产(万元)174658.97176862.92181886.85183899.46186173.13
总负债(万元)17760.7719877.2821352.8223572.2718988.92
归属于母公司股东权益合计(万元)156898.20156985.64160534.03160327.19167184.21
股东权益合计(万元)156898.20156985.64160534.03160327.19167184.21
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512600.00
资本公积(万元)62111.0062111.0062111.0062111.0061798.03
未分配利润(万元)75466.4275553.8779102.2578895.4186835.83
经营活动产生的现金流量净额(万元)10912.895995.985214.552695.345259.16
经营活动现金流入小计(万元)36398.4324474.5613705.6469039.9461337.17
经营活动现金流出小计(万元)25485.5418478.598491.0966344.6156078.01
投资活动产生的现金流量净额(万元)-1408.75902.7310603.27-12860.762553.30
投资活动现金流入小计(万元)46314.6826203.3719146.17129661.25124133.18
投资活动现金流出小计(万元)47723.4325300.648542.90142522.02121579.88
筹资活动产生的现金流量净额(万元)-3154.46-3158.34---6907.23-9069.65
筹资活动现金流入小计(万元)9.155.27--2160.03--
筹资活动现金流出小计(万元)3163.613163.61--9067.269069.65
期末现金及现金等价物余额(万元)19429.1916871.4228916.8313073.3328877.82
最后修改日期2024-10-292024-08-262024-04-222024-04-222023-10-24
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。